000 01311 a2200337 4500
005 20250516020824.0
264 0 _c20110214
008 201102s 0 0 eng d
022 _a1538-3687
024 7 _a10.1001/archneurol.2010.323
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLevin, Dimitriy
245 0 0 _aWarfarin therapy does not increase risk of symptomatic intracerebral hemorrhage in eligible patients after intravenous thrombolysis.
_h[electronic resource]
260 _bArchives of neurology
_cJan 2011
300 _a135; author reply 135-6 p.
_bdigital
500 _aPublication Type: Comment; Letter; Research Support, U.S. Gov't, Non-P.H.S.
650 0 4 _aCerebral Hemorrhage
_xchemically induced
650 0 4 _aHumans
650 0 4 _aInjections, Intravenous
650 0 4 _aRisk Factors
650 0 4 _aThrombolytic Therapy
650 0 4 _aTissue Plasminogen Activator
_xadministration & dosage
650 0 4 _aWarfarin
_xadministration & dosage
700 1 _aSmith, Don B
700 1 _aCumbler, Ethan
700 1 _aCarter, Jeffrey
700 1 _aGlasheen, Jeffrey J
700 1 _aJones, William
773 0 _tArchives of neurology
_gvol. 68
_gno. 1
_gp. 135; author reply 135-6
856 4 0 _uhttps://doi.org/10.1001/archneurol.2010.323
_zAvailable from publisher's website
999 _c20505008
_d20505008